SLC12A2 — Solute Carrier Family 12 Member 2 (Na-K-2Cl Co-transporter 2)

SLC12A2 — Solute Carrier Family 12 Member 2 (Na-K-2Cl Co-transporter 2)

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">SLC12A2 — Solute Carrier Family 12 Member 2 (Na-K-2Cl Co-transporter 2)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>SLC12A2</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Solute Carrier Family 12 Member 1 (Na-K-2Cl Co-transporter 1)</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>5q23</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>[6558](https://www.ncbi.nlm.nih.gov/gene/6558)</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>[600840](https://www.omim.org/entry/600840)</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000144659</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[P55012](https://www.uniprot.org/uniprot/P55012)</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Delpire-McNeill syndrome, Hearing loss (AD78), Kilquist syndrome, Schizophrenia, Temporal lobe epilepsy</td>
</tr>
</table>

{{.infobox .infobox-gene}}

Overview

The SLC12A2 gene encodes the Na⁺/K⁺/Cl⁻ cotransporter 1 (NKCC1), a critical membrane protein that mediates the coupled transport of sodium, potassium, and chloride ions across cell membranes. NKCC1 is essential for maintaining ionic balance, cell volume regulation, and transepithelial chloride transport throughout the body [@nkcc].

SLC12A2 — Solute Carrier Family 12 Member 2 (Na-K-2Cl Co-transporter 2)

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">SLC12A2 — Solute Carrier Family 12 Member 2 (Na-K-2Cl Co-transporter 2)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>SLC12A2</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Solute Carrier Family 12 Member 1 (Na-K-2Cl Co-transporter 1)</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>5q23</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>[6558](https://www.ncbi.nlm.nih.gov/gene/6558)</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>[600840](https://www.omim.org/entry/600840)</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000144659</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[P55012](https://www.uniprot.org/uniprot/P55012)</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Delpire-McNeill syndrome, Hearing loss (AD78), Kilquist syndrome, Schizophrenia, Temporal lobe epilepsy</td>
</tr>
</table>

{{.infobox .infobox-gene}}

Overview

The SLC12A2 gene encodes the Na⁺/K⁺/Cl⁻ cotransporter 1 (NKCC1), a critical membrane protein that mediates the coupled transport of sodium, potassium, and chloride ions across cell membranes. NKCC1 is essential for maintaining ionic balance, cell volume regulation, and transepithelial chloride transport throughout the body [@nkcc].

While initially characterized in renal tissue (where NKCC2, encoded by SLC12A1, is the dominant isoform), NKCC1 has broad tissue distribution with particularly important functions in the nervous system. The transporter is expressed in neuronal cell bodies and projections, where it plays a fundamental role in regulating intracellular chloride concentrations that directly influence neuronal excitability [@nkcca].

Role in Neuronal Function

Chloride Homeostasis and GABA Signaling

One of the most critical functions of NKCC1 in the brain is its role in maintaining intracellular chloride concentrations. During early neuronal development, NKCC1 activity keeps intracellular Cl⁻ levels elevated, which determines the polarity of GABAergic signaling. GABA, the primary inhibitory neurotransmitter in the adult brain, typically exerts hyperpolarizing effects by activating GABA-A receptors. However, when NKCC1 is highly active, the Cl⁻ gradient can be reduced, making GABA's effects more depolarizing [@gabaergic].

This developmental switch from NKCC1-dominant to KCC2-dominant (encoded by [SLC12A5](/genes/slc12a5)) chloride extrusion is crucial for normal brain development and the maturation of inhibitory circuits. Dysregulation of this process has been implicated in various neurological conditions.

Blood-Brain Barrier Maintenance

NKCC1 plays an important role in maintaining the integrity of the [blood-brain barrier](/entities/blood-brain-barrier) (BBB). The transporter helps regulate fluid and ion transport across endothelial cells, which is essential for BBB function. Impaired NKCC1 activity has been associated with BBB dysfunction, a feature common to many neurodegenerative diseases [@bloodbrain].

Cell Volume Regulation

As a major contributor to cellular ion homeostasis, NKCC1 is critical for cell volume regulation. [Neurons](/entities/neurons) are particularly sensitive to volume changes, and proper NKCC1 function helps protect against excitotoxicity and cellular stress. This function becomes especially relevant in conditions involving ischemic injury or metabolic stress [@nkccb].

Disease Associations

Delpire-McNeill Syndrome

Delpire-McNeill syndrome (OMIM: 619083) is a neurological condition caused by pathogenic variants in SLC12A2. The syndrome is characterized by developmental delay, speech impairment, and various neurological features. This directly demonstrates the critical importance of NKCC1 for human brain development and function [@delpiremcneill].

Hearing Loss

SLC12A2 variants have been linked to autosomal dominant hearing loss (AD78, OMIM: 619081). The inner ear relies heavily on potassium recycling for proper hair cell function, and NKCC1 contributes to maintaining the endolymphatic potassium gradient essential for auditory transduction [@association].

Kilquist Syndrome

Kilquist syndrome (OMIM: 619080) is another neurological disorder associated with SLC12A2 mutations, characterized by hearing impairment and neurological features including developmental delays [@kilquist].

Schizophrenia

Altered NKCC1 expression has been implicated in schizophrenia. Studies have shown changes in the NKCC1 to KCC2 mRNA ratio in the brains of individuals with schizophrenia, suggesting that dysregulated chloride homeostasis may contribute to the excitatory/inhibitory imbalance observed in this disorder [@nkccc].

Temporal Lobe Epilepsy

Epilepsy research has revealed altered NKCC1 expression and methylation patterns in refractory temporal lobe epilepsy. The dysregulation of chloride transporters is thought to contribute to hyperexcitability and seizure generation [@methylation].

Expression Pattern

SLC12A2 is expressed broadly across multiple tissues, with high expression in the colon, stomach, and various secretory epithelia. In the brain, NKCC1 is expressed in neurons, [astrocytes](/entities/astrocytes), and endothelial cells of the blood-brain barrier. During fetal development, expression is detected in various brain regions, including the [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), and cerebellum [@slca].

Therapeutic Implications

NKCC1 represents a potential therapeutic target for various neurological conditions. Bumetanide, a loop diuretic that inhibits NKCC1, has been explored as a potential treatment for disorders involving excessive neuronal excitation, including epilepsy and schizophrenia. However, the broad expression of NKCC1 and its important functions in peripheral tissues limit the therapeutic window of systemic NKCC1 inhibitors [@bumetanide].

Relationship to Neurodegenerative Diseases

While SLC12A2 is not directly implicated in the primary pathogenesis of Alzheimer's disease or Parkinson's disease, its role in neuronal ion homeostasis, blood-brain barrier maintenance, and response to cellular stress makes it relevant to the neurodegenerative process. Conditions that disrupt ionic homeostasis, including excitotoxicity and oxidative stress, may be exacerbated by altered NKCC1 function. Additionally, the blood-brain barrier dysfunction observed in Alzheimer's disease could involve alterations in NKCC1 activity [@bloodbraina].

See Also

• [SLC12A1](/genes/slc12a1) - NKCC2 (kidney-specific isoform)
• [SLC12A5](/genes/slc12a5) - KCC2 (neuronal chloride exporter)
• [GABA signaling](/mechanisms/gaba-signaling)
• [Blood-brain barrier](/mechanisms/blood-brain-barrier)

References